First, we identified the key miRNA (miR-485-5p) and target gene (E2F1) through bioinformatics analysis and found that CDDP treatment upregulated miR-485-5p levels in glioma cells and downregulated E2F1 levels. Here, E2F1 is linked to central nervous system cancer.